NCT02602080

Brief Summary

Nausea after surgery may negatively influence patient satisfaction, may delay discharge, and cause unexpected hospital admissions. The trend toward ambulatory surgery has increased the focus on postoperative nausea, but published evidence is not based on standardized criteria for assessment. Therefore, the results for postoperative nausea are very diverse, especially reports on nausea incidence after regional anesthesia, i.e. spinal anesthesia. When peripheral nerve blocks have been applied for postoperative pain control, they significantly reduce postoperative pain, opioid consumption and side effects; patients receiving general anesthesia (GA) and nerve blocks are thought likely to have less nausea than patients receiving GA alone. This study is a pilot study looking at the incidence and intensity of nausea after orthopedic surgery under nerve blocks in foot and ankle (FA) patients and under nerve blocks with either sedation or GA in total shoulder arthroplasty (TSA) patients. The results of this study will help power a future randomized controlled trial, comparing the incidence and intensity of nausea in FA patients receiving GA through laryngeal mask airway (LMA) versus spinal anesthesia.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
55

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Dec 2015

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

November 4, 2015

Completed
7 days until next milestone

First Posted

Study publicly available on registry

November 11, 2015

Completed
20 days until next milestone

Study Start

First participant enrolled

December 1, 2015

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2016

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 1, 2016

Completed
2.8 years until next milestone

Results Posted

Study results publicly available

February 4, 2019

Completed
Last Updated

October 2, 2019

Status Verified

September 1, 2019

Enrollment Period

4 months

First QC Date

November 4, 2015

Results QC Date

June 28, 2018

Last Update Submit

September 18, 2019

Conditions

Outcome Measures

Primary Outcomes (4)

  • Number of Participants With Nausea 1 Hour After Post-anesthesia Care Unit (PACU) Admission

    Yes/no response to whether patient had nausea in the PACU 1 hour after admission. If yes, investigators will seek out intensity

    1 hour after surgery

  • Number of Participants With Nausea

    Yes/no question. If yes, the investigators will then seek intensity of nausea.

    Average 2 hours after surgery (at discharge from the recovery room after surgery)

  • Intensity of Nausea

    On an 11 grade Likert scale (0=no nausea, 10=worst possible nausea)

    1 hour after surgery

  • Intensity of Nausea

    On a 11 grade Likert scale (0=no nausea, 10=worst possible nausea)

    2 hours after surgery

Secondary Outcomes (6)

  • Antiemetic Consumption

    Duration of stay in recovery room after surgery (average 2 hours)

  • Number of Participants With Emesis

    1 hour after surgery

  • Number of Participants With Emesis

    Average 2 hours after surgery (at discharge from the recovery room after surgery)

  • Number of Participants Satisfied With Anesthesia

    PACU before discharge, an average of 2 hours

  • Patients Receiving Opioids in the PACU

    PACU stay before discharge (average 2 hours)

  • +1 more secondary outcomes

Study Arms (3)

FA patients under popliteal block + spinal + sedation

Foot and ankle patients under popliteal block+ spinal+ sedation

TSA patients under brachial plexus block + general (LMA)

Total shoulder arthroscopy patients under brachial plexus block + general (LMA)

TSA patients under brachial plexus block + sedation

Total shoulder arthroplasty patients under brachial plexus block + sedation

Eligibility Criteria

Age18 Years - 99 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients undergoing elective orthopedic surgery for foot and ankle or total shoulder replacement that are within the age limit and meet eligibility criteria.

You may qualify if:

  • Elective surgery
  • Age 18-99
  • Patients who are capable to provide informed consent and answer questions in English,
  • For FA patients: Planned neuraxial anesthesia + nerve block for postsurgical analgesia,
  • For TSA patients: Planned brachial plexus nerve block + either general anesthesia or IV sedation.

You may not qualify if:

  • Incapable to provide informed consent
  • Contraindications for regional or LMA anesthesia (anticoagulation, infection at injection site)
  • Anticipated difficult airway
  • Body mass index\>35
  • Anticipated surgical procedure time less than 1 hour or more than 4 hours,
  • History of severe postoperative nausea and/or vomiting
  • American Society of Anesthesiologists physical status classification \>3
  • Neuropathy
  • Pregnant or nursing women
  • Chronic opioid use (daily use of opioids one month prior to surgery/ patients requiring chronic pain interventions)
  • Prone position planned for surgery
  • Obstructive sleep apnea
  • Known allergy/sensitivity to any study medications

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Hospital for Special Surgery, New York

New York, New York, 10021, United States

Location

MeSH Terms

Conditions

NauseaVomiting

Condition Hierarchy (Ancestors)

Signs and Symptoms, DigestiveSigns and SymptomsPathological Conditions, Signs and Symptoms

Limitations and Caveats

Limitations included generalizability, as the study was limited by anesthetic regimen, type of surgery, and patient population. We felt it was inappropriate to randomize general or spinal anesthesia for the purpose of this study.

Results Point of Contact

Title
George Birch
Organization
Hospital for Special Surgery

Study Officials

  • Jacques Ya Deau, MD, PhD

    Hospital for Special Surgery, New York

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
Yes

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

November 4, 2015

First Posted

November 11, 2015

Study Start

December 1, 2015

Primary Completion

April 1, 2016

Study Completion

April 1, 2016

Last Updated

October 2, 2019

Results First Posted

February 4, 2019

Record last verified: 2019-09

Locations